During the past decade, Akron Nephrology Associates, Inc. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Akron Nephrology Associates, Inc." #1 sponsor was "Goldfinch Bio, Inc." with 2 trials, followed by "AMAG Pharmaceuticals, Inc." with 1 trials sponsored, "Kezar Life Sciences, Inc." with 1 trials sponsored, "Reata Pharmaceuticals, Inc." with 1 trials sponsored and "Travere Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Akron Nephrology Associates, Inc." are "Diabetic Nephropathies" (2 trials), "Glomerulosclerosis, Focal Segmental" (2 trials), "Alport Syndrome" (1 trials), "Chronic Kidney Disease; Iron Deficiency Anemia" (1 trials) and "Diabetes Complications" (1 trials). Many other conditions were trialed in "Akron Nephrology Associates, Inc." in a lesser frequency.

Most popular intervention types in "Akron Nephrology Associates, Inc." are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bardoxolone Methyl" (1 trials), "Diabetic Nephropathy (DN)" (1 trials), "FSGS/TR-MCD" (1 trials), "Ferumoxytol" (1 trials) and "GFB-887" (1 trials). Other intervention names were less common.

The vast majority of trials in "Akron Nephrology Associates, Inc." are 6 trials for "All" genders.

Currently, there are NaN active trials in "Akron Nephrology Associates, Inc.". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Akron Nephrology Associates, Inc., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Akron Nephrology Associates, Inc., 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".